Prof Michael J Reardon (Houston Methodist, Texas, US) and Dr Nicolas van Mieghem (Rotterdam, NL) discuss the corevalve low-risk TAVR trial - self-expanding transcatheter or surgical aortic valve replacement in patients at low risk of surgical mortality.
Filmed on site at ACC 2019 by Radcliffe Cardiology.

Videography: Josh Birch

Educational lead: Liam O'Neill (Chief Operating Officer)